News ArticleZydus Lifesciences Notifies Lost Share Certificate for 3000 Equity Shares Held by Shivanand Patel
Company to issue duplicate certificate pending no objection within 7 days from October 30, 2026
Zydus Lifesciences Limited has published a notice regarding the loss of an equity share certificate held by shareholder Shivanand Patel covering 3000 shares. The company cautions the public against dealing with the lost certificate and will issue a duplicate certificate after a 7-day objection period from October 30, 2026.
Zydus Lifesciences Limited
General / Other
Zydus Lifesciences Limited has publicly announced the loss of an equity share certificate owned by shareholder Shivanand Patel for 3000 shares. The company will issue a duplicate certificate if no objections are raised within 7 days of the notice published on October 30, 2026.
The lost share certificate is numbered 2105 under folio number 2174821-057043, covering 3000 equity shares belonging to shareholder Shivanand Patel.
The notice was published in the Financial Express newspaper's English and Gujarati editions on October 30, 2026, cautioning the public not to deal with the lost certificate to avoid any loss or damage.
If no objections are received within 7 days of the notice's publication date, Zydus Lifesciences will proceed with issuing a duplicate share certificate to the shareholder.
The company disclaims responsibility for losses or damages arising from transactions involving the lost share certificate prior to the issuance of the duplicate.
Highlights
- Lost share certificate pertains to 3000 equity shares owned by Shivanand Patel.
- Share certificate number is 2105 under folio number 2174821-057043.
- Notice published on October 30, 2026, in Financial Express (English & Gujarati).
- 7-day objection period from the date of publication before issuing a duplicate.
- Public cautioned against dealing with the lost certificate.
- Duplicate certificate issuance planned if no objections arise.
Key Data Snapshot
What happened
- Zydus Lifesciences Limited received an intimation from shareholder Shivanand Patel that he lost his equity share certificate representing 3000 shares.
- The company published an official notice about the lost share certificate in Financial Express on October 30, 2026.
- The shareholder’s certificate is identified by folio number 2174821-057043 and certificate number 2105.
Next milestones
- The company will issue a duplicate share certificate if no objections are received within 7 days from the notice publication date.
- The public is warned not to deal with the lost share certificate during this period to prevent any loss or damage.
Regulatory and governance context
- The notice was issued in compliance with regulatory requirements for lost share certificates.
- It was published in both English and Gujarati editions of the Financial Express newspaper as part of the legal process to inform stakeholders.
Highlights
- Lost share certificate pertains to 3000 equity shares owned by Shivanand Patel.
- Share certificate number is 2105 under folio number 2174821-057043.
- Notice published on October 30, 2026, in Financial Express (English & Gujarati).
- 7-day objection period from the date of publication before issuing a duplicate.
- Public cautioned against dealing with the lost certificate.
- Duplicate certificate issuance planned if no objections arise.
Disclosures
- Listing Obligations and Disclosure Requirements (LODR) Regulations
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
GAIL (India) Limited Reports ₹11,611.44 Crore Profit Before Tax for Q2 and H1 FY2026-27
GAIL (India) Limited announced its unaudited standalone financial results for the quarter and half year ended September 30, 2026, recording ₹11,611.44 crore profit before tax for the half year and total income of ₹86,116.52 crore.
Read Full Story
Max Healthcare Approves Q2 2026 Financial Results and Major Expansion Projects in Noida and Vaishali
Max Healthcare Institute Limited has approved its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The Board also approved capital expenditure plans totaling approximately ₹190 Crore to expand its hospitals in Noida and Vaishali, and revised the Gurugram hospital project cost and timeline.
Read Full Story
Max Healthcare Q2 FY27 Revenue Rises 20% to ₹3,219 Crore; PAT Increases 10% to ₹448 Crore
Max Healthcare Institute Limited reported a 20% year-on-year increase in gross revenue to ₹3,219 crore for the second quarter ended September 30, 2026, alongside a 10% rise in profit after tax to ₹448 crore. Operational bed capacity expanded by 16% year-on-year to 5,518 beds, supporting increased patient service volume.
Read Full Story
